Relationship between postpartum depression and plasma vasopressin level at 6-8 weeks postpartum: a cross-sectional...

Area of Science:

• Neuroendocrinology
• Reproductive Psychiatry
• Maternal Health

Background:

• Postpartum depression (PPD) significantly impacts maternal-infant well-being.
• Arginine vasopressin (AVP) is implicated in mood disorders, including depression.

Purpose of the Study:

• To investigate the association between plasma AVP concentrations and PPD severity.
• To explore AVP's role in the development of postpartum depression.

Main Methods:

• Cross-sectional study involving 303 pregnant women.
• Plasma AVP levels measured via ELISA in 24 PPD patients and 66 controls.
• Edinburgh Postnatal Depression Scale (EPDS) used for PPD assessment.

Main Results:

• A significant positive correlation was found between plasma AVP levels and EPDS scores (r=0.658).
• Mean plasma AVP was significantly higher in the PPD group (41.35 ng/ml) vs. controls (26.01 ng/ml).
• Increased AVP, multiparity, and non-exclusive breastfeeding were associated with higher PPD odds.

Conclusions:

• Elevated plasma AVP is a significant contributor to clinical PPD.
• AVP may influence PPD through the hypothalamic-pituitary-adrenal (HPA) axis.
• Maternal gender preference and primiparity were associated with reduced PPD risk.